{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:48:27Z","timestamp":1792788507407,"version":"4.5.0"},"reference-count":112,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100019383","name":"Cipla Ltd","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100019383","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatol Ther (Heidelb)"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s13555-026-01681-6","type":"journal-article","created":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T08:04:40Z","timestamp":1774944280000},"page":"2607-2638","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Expert Consensus on the Rational Approach to Isotretinoin Usage for Effective Management of Acne: ERAISE ACNE Recommendations"],"prefix":"10.1007","volume":"16","author":[{"given":"Sanjiv","family":"Kandhari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8035-1788","authenticated-orcid":false,"given":"Jayakar","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3648-9974","authenticated-orcid":false,"given":"Niti","family":"Khunger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6997-1513","authenticated-orcid":false,"given":"Maya","family":"Vedamurthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0550-5871","authenticated-orcid":false,"given":"Kiran","family":"Godse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3319-2080","authenticated-orcid":false,"given":"Abir","family":"Saraswat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3194-9721","authenticated-orcid":false,"given":"Nina","family":"Madnani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9461-3198","authenticated-orcid":false,"given":"Vijay","family":"Somani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1829-1067","authenticated-orcid":false,"given":"Sushil","family":"Tahiliani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1138-7266","authenticated-orcid":false,"given":"Bela","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. R.","family":"Srinivas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7202-6654","authenticated-orcid":false,"given":"Asit","family":"Mittal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-8022-8448","authenticated-orcid":false,"given":"Mukesh","family":"Girdhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-7697-7532","authenticated-orcid":false,"given":"Maleeka","family":"Sachdeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachin","family":"Varma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2985-9623","authenticated-orcid":false,"given":"Manjunath","family":"Shenoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1909-6930","authenticated-orcid":false,"given":"Shyamanta","family":"Barua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5998-2430","authenticated-orcid":false,"given":"Abhishek","family":"De","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4971-746X","authenticated-orcid":false,"given":"Akshay","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5873-227X","authenticated-orcid":false,"given":"Aseem","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,31]]},"reference":[{"key":"1681_CR1","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1016\/j.jaad.2023.12.038","volume":"90","author":"JH Saurat","year":"2024","unstructured":"Saurat JH, Halioua B, Baissac C, et al. Epidemiology of acne and rosacea: a worldwide global study. J Am Acad Dermatol. 2024;90:1016\u20138. https:\/\/doi.org\/10.1016\/j.jaad.2023.12.038.","journal-title":"J Am Acad Dermatol"},{"key":"1681_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrep.2023.101578","volume":"36","author":"M Vasam","year":"2023","unstructured":"Vasam M, Korutla S, Bohara RA. Acne vulgaris: a review of the pathophysiology, treatment, and recent nanotechnology based advances. Biochem Biophys Rep. 2023;36:101578. https:\/\/doi.org\/10.1016\/j.bbrep.2023.101578.","journal-title":"Biochem Biophys Rep"},{"key":"1681_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25105302","volume":"25","author":"HJ Kim","year":"2024","unstructured":"Kim HJ, Kim YH. Exploring acne treatments: from pathophysiological mechanisms to emerging therapies. Int J Mol Sci. 2024;25:5302. https:\/\/doi.org\/10.3390\/ijms25105302.","journal-title":"Int J Mol Sci"},{"key":"1681_CR4","doi-asserted-by":"publisher","DOI":"10.4081\/dr.2021.8223","volume":"13","author":"F Al-Qarqaz","year":"2021","unstructured":"Al-Qarqaz F, Bodoor K, Baba A, et al. Post-acne hyperpigmentation: evaluation of risk factors and the use of artificial neural network as a predictive classifier. Dermatol Rep. 2021;13:8223. https:\/\/doi.org\/10.4081\/dr.2021.8223.","journal-title":"Dermatol Rep"},{"key":"1681_CR5","doi-asserted-by":"publisher","first-page":"3177","DOI":"10.1111\/jocd.13753","volume":"19","author":"S Sood","year":"2020","unstructured":"Sood S, Jafferany M, Vinaya Kumar S. Depression, psychiatric comorbidities, and psychosocial implications associated with acne vulgaris. J Cosmet Dermatol. 2020;19:3177\u201382. https:\/\/doi.org\/10.1111\/jocd.13753.","journal-title":"J Cosmet Dermatol"},{"key":"1681_CR6","doi-asserted-by":"publisher","first-page":"731","DOI":"10.2147\/CCID.S406235","volume":"16","author":"C Zhou","year":"2023","unstructured":"Zhou C, Vempati A, Tam C, et al. Beyond the surface: a deeper look at the psychosocial impacts of acne scarring. Clin Cosmet Investig Dermatol. 2023;16:731\u20138. https:\/\/doi.org\/10.2147\/CCID.S406235.","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"1681_CR7","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1001\/jamadermatol.2023.4487","volume":"160","author":"A Shields","year":"2024","unstructured":"Shields A, Nock MR, Ly S, et al. Evaluation of stigma toward individuals with acne. JAMA Dermatol. 2024;160:93\u20138. https:\/\/doi.org\/10.1001\/jamadermatol.2023.4487.","journal-title":"JAMA Dermatol"},{"key":"1681_CR8","doi-asserted-by":"publisher","first-page":"196","DOI":"10.4103\/ijpd.IJPD_82_16","volume":"18","author":"R Sharma","year":"2017","unstructured":"Sharma R, Dogra S, Singh A, et al. Epidemiological patterns of acne vulgaris among adolescents in North India: a cross-sectional study and brief review of literature. Ind J Paediatr Derm. 2017;18:196\u2013201. https:\/\/doi.org\/10.4103\/ijpd.IJPD_82_16.","journal-title":"Ind J Paediatr Derm"},{"key":"1681_CR9","doi-asserted-by":"publisher","first-page":"33","DOI":"10.52403\/ijhsr.20210905","volume":"11","author":"S Shabnam","year":"2021","unstructured":"Shabnam S. A study on prevalence of acne vulgaris and its impact on quality of life in adolescents of Kendriya Vidyalaya\u2019s of Jalahalli area of Bangalore. Int J Health Sci Res. 2021;11:33\u201340. https:\/\/doi.org\/10.52403\/ijhsr.20210905.","journal-title":"Int J Health Sci Res"},{"key":"1681_CR10","doi-asserted-by":"publisher","first-page":"3672","DOI":"10.1111\/jocd.14040","volume":"20","author":"N Shah","year":"2021","unstructured":"Shah N, Shukla R, Chaudhari P, et al. Prevalence of acne vulgaris and its clinico-epidemiological pattern in adult patients: results of a prospective, observational study. J Cosmet Dermatol. 2021;20:3672\u20138. https:\/\/doi.org\/10.1111\/jocd.14040.","journal-title":"J Cosmet Dermatol"},{"key":"1681_CR11","doi-asserted-by":"publisher","first-page":"272","DOI":"10.4103\/0378-6323.51244","volume":"75","author":"B Adityan","year":"2009","unstructured":"Adityan B, Thappa DM. Profile of acne vulgaris\u2014a hospital-based study from South India. Indian J Dermatol Venereol Leprol. 2009;75:272\u20138. https:\/\/doi.org\/10.4103\/0378-6323.51244.","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"1681_CR12","doi-asserted-by":"publisher","first-page":"237","DOI":"10.18231\/j.ijced.2020.048","volume":"6","author":"D Dhoot","year":"2020","unstructured":"Dhoot D, Budamakuntla L, Parasramani S, et al. Acne in Indian population: an epidemiological study evaluating multiple factors. IP Indian J Clin Exp Dermatol. 2020;6:237\u201342. https:\/\/doi.org\/10.18231\/j.ijced.2020.048.","journal-title":"IP Indian J Clin Exp Dermatol"},{"key":"1681_CR13","doi-asserted-by":"publisher","first-page":"335","DOI":"10.4103\/0378-6323.95450","volume":"78","author":"N Khunger","year":"2012","unstructured":"Khunger N, Kumar C. A clinico-epidemiological study of adult acne: is it different from adolescent acne? Indian J Dermatol Venereol Leprol. 2012;78:335\u201341. https:\/\/doi.org\/10.4103\/0378-6323.95450.","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"1681_CR14","doi-asserted-by":"publisher","first-page":"568","DOI":"10.3399\/bjgp21X717977","volume":"71","author":"J Wilcock","year":"2021","unstructured":"Wilcock J, Kuznetsov L, Ravenscroft J, Rafiq MI, Healy E, Guideline Committee. New NICE guidance on acne vulgaris: implications for first-line management in primary care. Br J Gen Pract. 2021;71:568\u201370. https:\/\/doi.org\/10.3399\/bjgp21X717977.","journal-title":"Br J Gen Pract"},{"key":"1681_CR15","doi-asserted-by":"publisher","first-page":"1006.e1","DOI":"10.1016\/j.jaad.2023.12.017","volume":"90","author":"RV Reynolds","year":"2024","unstructured":"Reynolds RV, Yeung H, Cheng CE, et al. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol. 2024;90:1006.e1-1006.e30. https:\/\/doi.org\/10.1016\/j.jaad.2023.12.017.","journal-title":"J Am Acad Dermatol"},{"key":"1681_CR16","first-page":"1","volume":"75","author":"R Kubba","year":"2009","unstructured":"Kubba R, Bajaj AK, Thappa DM, et al. Acne in India: guidelines for management - IAA consensus document. Indian J Dermatol Venereol Leprol. 2009;75:1\u201362.","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"1681_CR17","unstructured":"Acne vulgaris: management. London: National institute for health and care excellence (NICE); (NICE Guideline, No. 198.). https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK573056\/. Accessed 14 Jan 2026."},{"key":"1681_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11247535","volume":"11","author":"A Tobiasz","year":"2022","unstructured":"Tobiasz A, Nowicka D, Szepietowski JC. Acne vulgaris-novel treatment options and factors affecting therapy adherence: a narrative review. J Clin Med. 2022;11:7535. https:\/\/doi.org\/10.3390\/jcm11247535.","journal-title":"J Clin Med"},{"key":"1681_CR19","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.jgar.2024.07.005","volume":"39","author":"M Beig","year":"2024","unstructured":"Beig M, Shirazi O, Ebrahimi E, et al. Prevalence of antibiotic-resistant Cutibacterium acnes (formerly Propionibacterium acnes) isolates, a systematic review and meta-analysis. J Glob Antimicrob Resist. 2024;39:82\u201391. https:\/\/doi.org\/10.1016\/j.jgar.2024.07.005.","journal-title":"J Glob Antimicrob Resist"},{"key":"1681_CR20","doi-asserted-by":"publisher","DOI":"10.1111\/j.1610-0387.2009.07238.x","volume":"8","author":"R Ganceviciene","year":"2010","unstructured":"Ganceviciene R, Zouboulis CC. Isotretinoin: state of the art treatment for acne vulgaris. JDDG: J Deutsch Dermatol Ges. 2010;8:S47. https:\/\/doi.org\/10.1111\/j.1610-0387.2009.07238.x.","journal-title":"JDDG: J Deutsch Dermatol Ges"},{"key":"1681_CR21","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1067\/mjd.2002.120529","volume":"46","author":"DK Wysowski","year":"2002","unstructured":"Wysowski DK, Swann J, Vega A. Use of isotretinoin (Accutane) in the United States: rapid increase from 1992 through 2000. J Am Acad Dermatol. 2002;46:505\u20139. https:\/\/doi.org\/10.1067\/mjd.2002.120529.","journal-title":"J Am Acad Dermatol"},{"key":"1681_CR22","unstructured":"Central Drugs Standard Control Organisation CDSCO. New Delhi (IN): CDSCO. https:\/\/cdscoonline.gov.in\/CDSCO\/Drugs. Accessed 28 Apr 2025."},{"key":"1681_CR23","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1111\/bjd.15668","volume":"178","author":"IA Vallerand","year":"2018","unstructured":"Vallerand IA, Lewinson RT, Farris MS, et al. Efficacy and adverse events of oral isotretinoin for acne: a systematic review. Br J Dermatol. 2018;178:76\u201385. https:\/\/doi.org\/10.1111\/bjd.15668.","journal-title":"Br J Dermatol"},{"key":"1681_CR24","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1001\/jamadermatol.2015.3091","volume":"152","author":"YH Lee","year":"2016","unstructured":"Lee YH, Scharnitz TP, Muscat J, et al. Laboratory monitoring during isotretinoin therapy for acne: a systematic review and meta-analysis. JAMA Dermatol. 2016;152:35\u201344. https:\/\/doi.org\/10.1001\/jamadermatol.2015.3091.","journal-title":"JAMA Dermatol"},{"key":"1681_CR25","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.58840","volume":"16","author":"RF Al-Sheyab","year":"2024","unstructured":"Al-Sheyab RF, Alshiyab D, Al-Shagarin RA, et al. Prescribing patterns of isotretinoin for acne among dermatologists in central Jordan. Cureus. 2024;16:e58840. https:\/\/doi.org\/10.7759\/cureus.58840.","journal-title":"Cureus"},{"key":"1681_CR26","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1080\/17512433.2016.1213629","volume":"9","author":"LB Bauer","year":"2016","unstructured":"Bauer LB, Ornelas JN, Elston DM, et al. Isotretinoin: controversies, facts, and recommendations. Expert Rev Clin Pharmacol. 2016;9:1435\u201342. https:\/\/doi.org\/10.1080\/17512433.2016.1213629.","journal-title":"Expert Rev Clin Pharmacol"},{"key":"1681_CR27","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1111\/jdv.13776","volume":"30","author":"A Nast","year":"2016","unstructured":"Nast A, Dr\u00e9no B, Bettoli V, et al. European evidence-based (S3) guideline for the treatment of acne - update 2016 - short version. J Eur Acad Dermatol Venereol. 2016;30:1261\u20138. https:\/\/doi.org\/10.1111\/jdv.13776.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1681_CR28","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1503\/cmaj.140665","volume":"188","author":"Y Asai","year":"2016","unstructured":"Asai Y, Baibergenova A, Dutil M, et al. Management of acne: Canadian clinical practice guideline. CMAJ. 2016;188:118\u201326. https:\/\/doi.org\/10.1503\/cmaj.140665.","journal-title":"CMAJ"},{"key":"1681_CR29","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.abd.2020.09.001","volume":"95","author":"E Bagatin","year":"2020","unstructured":"Bagatin E, Costa CS, da Rocha MAD, et al. Consensus on the use of oral isotretinoin in dermatology - Brazilian Society of Dermatology. An Bras Dermatol. 2020;95:19\u201338. https:\/\/doi.org\/10.1016\/j.abd.2020.09.001.","journal-title":"An Bras Dermatol"},{"key":"1681_CR30","unstructured":"Oxford Centre for Evidence-Based Medicine (OCEBM). Oxford (UK): Centre for Evidence-Based Medicine; 2020. https:\/\/www.cebm.ox.ac.uk\/resources\/levels-of-evidence\/ocebm-levels-of-evidence. Accessed 11 July 2025."},{"key":"1681_CR31","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.jpainsymman.2011.09.009","volume":"44","author":"S J\u00fcnger","year":"2012","unstructured":"J\u00fcnger S, Payne S, Brearley S, et al. Consensus building in palliative care: a Europe-wide Delphi study on common understandings and conceptual differences. J Pain Symptom Manage. 2012;44:192\u2013205. https:\/\/doi.org\/10.1016\/j.jpainsymman.2011.09.009.","journal-title":"J Pain Symptom Manage"},{"key":"1681_CR32","doi-asserted-by":"publisher","first-page":"2062","DOI":"10.1093\/humrep\/dead184","volume":"38","author":"K Lundin","year":"2023","unstructured":"Lundin K, Bentzen JG, Bozdag G, et al. Good practice recommendations on add-ons in reproductive medicine. Hum Reprod. 2023;38:2062\u2013104. https:\/\/doi.org\/10.1093\/humrep\/dead184.","journal-title":"Hum Reprod"},{"key":"1681_CR33","unstructured":"National Institute for Health and Care Excellence (NICE). London (UK): NICE. https:\/\/www.nice.org.uk\/process\/pmg20\/resources\/developing-nice-guidelines-the-manual-pdf-72286708700869. Accessed 14 July 2025."},{"key":"1681_CR34","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1002\/jvc2.154","volume":"2","author":"AU Daly","year":"2023","unstructured":"Daly AU, Baptista Gon\u00e7alves R, Lau E, et al. A systematic review of isotretinoin dosing in acne vulgaris. JEADV Clin Pract. 2023;2:432\u201349. https:\/\/doi.org\/10.1002\/jvc2.154.","journal-title":"JEADV Clin Pract"},{"key":"1681_CR35","doi-asserted-by":"publisher","first-page":"682","DOI":"10.5114\/ada.2022.118921","volume":"39","author":"P Brzezinski","year":"2022","unstructured":"Brzezinski P, Wollina U, Smigielski J, et al. The use of isotretinoin in acne therapy in early childhood and its effect on the occurrence of acne symptoms later in life. Eight-year follow-up. Postepy Dermatol Alergol. 2022;39:682\u20137. https:\/\/doi.org\/10.5114\/ada.2022.118921.","journal-title":"Postepy Dermatol Alergol"},{"key":"1681_CR36","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/978-3-030-44766-3_43","volume-title":"Textbook on scar management","author":"H Tchero","year":"2020","unstructured":"Tchero H. Management of scars in skin of color. In: Textbook on scar management. Cham: Springer; 2020. p. 371\u20137."},{"key":"1681_CR37","first-page":"20","volume":"3","author":"EC Davis","year":"2010","unstructured":"Davis EC, Callender VD. Postinflammatory hyperpigmentation: a review of the epidemiology, clinical features, and treatment options in skin of color. J Clin Aesthet Dermatol. 2010;3:20\u201331.","journal-title":"J Clin Aesthet Dermatol"},{"key":"1681_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2017.01381","volume":"8","author":"AE Ryan-Kewley","year":"2017","unstructured":"Ryan-Kewley AE, Williams DR, Hepburn N, et al. Non-antibiotic isotretinoin treatment differentially controls Propionibacterium acnes on skin of acne patients. Front Microbiol. 2017;8:1381. https:\/\/doi.org\/10.3389\/fmicb.2017.01381.","journal-title":"Front Microbiol"},{"key":"1681_CR39","doi-asserted-by":"publisher","first-page":"273","DOI":"10.2165\/00128071-200304040-00005","volume":"4","author":"R B\u00f6ni","year":"2003","unstructured":"B\u00f6ni R, Nehrhoff B. Treatment of gram-negative folliculitis in patients with acne. Am J Clin Dermatol. 2003;4:273\u20136. https:\/\/doi.org\/10.2165\/00128071-200304040-00005.","journal-title":"Am J Clin Dermatol"},{"key":"1681_CR40","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1590\/abd1806-4841.20198203","volume":"94","author":"E Bagatin","year":"2019","unstructured":"Bagatin E, Freitas THP, Rivitti-Machado MC, et al. Adult female acne: a guide to clinical practice. An Bras Dermatol. 2019;94:62\u201375. https:\/\/doi.org\/10.1590\/abd1806-4841.20198203.","journal-title":"An Bras Dermatol"},{"key":"1681_CR41","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.jaad.2016.11.028","volume":"77","author":"T Greywal","year":"2017","unstructured":"Greywal T, Zaenglein AL, Baldwin HE, et al. Evidence-based recommendations for the management of acne fulminans and its variants. J Am Acad Dermatol. 2017;77:109\u201317. https:\/\/doi.org\/10.1016\/j.jaad.2016.11.028.","journal-title":"J Am Acad Dermatol"},{"key":"1681_CR42","doi-asserted-by":"publisher","first-page":"943","DOI":"10.2147\/CCID.S234231","volume":"12","author":"V Bettoli","year":"2019","unstructured":"Bettoli V, Guerra-Tapia A, Herane MI, et al. Challenges and solutions in oral isotretinoin in acne: reflections on 35\u00a0years of experience. Clin Cosmet Investig Dermatol. 2019;12:943\u201351. https:\/\/doi.org\/10.2147\/CCID.S234231.","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"1681_CR43","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1370\/afm.2995","volume":"21","author":"CY Huang","year":"2023","unstructured":"Huang CY, Chang IJ, Bolick N, et al. Comparative efficacy of pharmacological treatments for acne vulgaris: a network meta-analysis of 221 randomized controlled trials. Ann Fam Med. 2023;21:358\u201369. https:\/\/doi.org\/10.1370\/afm.2995.","journal-title":"Ann Fam Med"},{"key":"1681_CR44","doi-asserted-by":"publisher","first-page":"162","DOI":"10.4161\/derm.1.3.9364","volume":"1","author":"A Layton","year":"2009","unstructured":"Layton A. The use of isotretinoin in acne. Dermatoendocrinol. 2009;1:162\u20139. https:\/\/doi.org\/10.4161\/derm.1.3.9364.","journal-title":"Dermatoendocrinol"},{"key":"1681_CR45","doi-asserted-by":"publisher","first-page":"2573","DOI":"10.2147\/DDDT.S427530","volume":"17","author":"A Paichitrojjana","year":"2023","unstructured":"Paichitrojjana A, Paichitrojjana A. Oral isotretinoin and its uses in dermatology: a review. Drug Des Devel Ther. 2023;17:2573\u201391. https:\/\/doi.org\/10.2147\/DDDT.S427530.","journal-title":"Drug Des Devel Ther"},{"key":"1681_CR46","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.jaad.2015.09.046","volume":"74","author":"AR Nagler","year":"2016","unstructured":"Nagler AR, Milam EC, Orlow SJ. The use of oral antibiotics before isotretinoin therapy in patients with acne. J Am Acad Dermatol. 2016;74:273\u20139. https:\/\/doi.org\/10.1016\/j.jaad.2015.09.046.","journal-title":"J Am Acad Dermatol"},{"key":"1681_CR47","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/j.jaad.2005.11.1061","volume":"54","author":"B Amichai","year":"2006","unstructured":"Amichai B, Shemer A, Grunwald MH. Low-dose isotretinoin in the treatment of acne vulgaris. J Am Acad Dermatol. 2006;54:644\u20136. https:\/\/doi.org\/10.1016\/j.jaad.2005.11.1061.","journal-title":"J Am Acad Dermatol"},{"key":"1681_CR48","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.1111\/jdv.16430","volume":"34","author":"C Dessinioti","year":"2020","unstructured":"Dessinioti C, Zouboulis CC, Bettoli V, et al. Comparison of guidelines and consensus articles on the management of patients with acne with oral isotretinoin. J Eur Acad Dermatol Venereol. 2020;34:2229\u201340. https:\/\/doi.org\/10.1111\/jdv.16430.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1681_CR49","doi-asserted-by":"publisher","first-page":"10","DOI":"10.7573\/dic.2021-10-9","volume":"11","author":"C Chiang","year":"2022","unstructured":"Chiang C, Ward M, Gooderham M. Dermatology: how to manage acne in skin of colour. Drugs Context. 2022;11:10\u20139. https:\/\/doi.org\/10.7573\/dic.2021-10-9.","journal-title":"Drugs Context"},{"key":"1681_CR50","first-page":"46","volume":"16","author":"CB Turk","year":"2023","unstructured":"Turk CB, Baykara Ulusan M, D\u00f6\u015f YM, et al. The effects of oral isotretinoin on atrophic acne scars measured by shear-wave elastography: an observational, single-center study. J Clin Aesthet Dermatol. 2023;16:46\u201351.","journal-title":"J Clin Aesthet Dermatol"},{"key":"1681_CR51","doi-asserted-by":"publisher","first-page":"245","DOI":"10.2147\/CCID.S158129","volume":"11","author":"AO Akinboro","year":"2018","unstructured":"Akinboro AO, Ezejiofor OI, Olanrewaju FO, et al. The impact of acne and facial post-inflammatory hyperpigmentation on quality of life and self-esteem of newly admitted Nigerian undergraduates. Clin Cosmet Investig Dermatol. 2018;11:245\u201352. https:\/\/doi.org\/10.2147\/CCID.S158129.","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"1681_CR52","first-page":"S18","volume":"14","author":"R Bellomo","year":"2021","unstructured":"Bellomo R, Brunner M, Tadjally E. New formulations of isotretinoin for acne treatment: expanded options and clinical implications. J Clin Aesthet Dermatol. 2021;14:S18\u201323.","journal-title":"J Clin Aesthet Dermatol"},{"key":"1681_CR53","doi-asserted-by":"publisher","first-page":"7","DOI":"10.2165\/11532280-000000000-00000","volume":"12","author":"MD Newman","year":"2011","unstructured":"Newman MD, Bowe WP, Heughebaert C, et al. Therapeutic considerations for severe nodular acne. Am J Clin Dermatol. 2011;12:7\u201314. https:\/\/doi.org\/10.2165\/11532280-000000000-00000.","journal-title":"Am J Clin Dermatol"},{"key":"1681_CR54","doi-asserted-by":"publisher","first-page":"279","DOI":"10.4103\/0378-6323.110748","volume":"79","author":"DD Arshdeep","year":"2013","unstructured":"Arshdeep DD. What\u2019s new in the management of acne? Indian J Dermatol Venereol Leprol. 2013;79:279\u201387. https:\/\/doi.org\/10.4103\/0378-6323.110748.","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"1681_CR55","doi-asserted-by":"publisher","DOI":"10.1111\/dth.14438","volume":"34","author":"A Sadeghzadeh-Bazargan","year":"2021","unstructured":"Sadeghzadeh-Bazargan A, Ghassemi M, Goodarzi A, et al. Systematic review of low-dose isotretinoin for treatment of acne vulgaris: focus on indication, dosage, regimen, efficacy, safety, satisfaction, and follow up, based on clinical studies. Dermatol Ther. 2021;34:e14438. https:\/\/doi.org\/10.1111\/dth.14438.","journal-title":"Dermatol Ther"},{"key":"1681_CR56","unstructured":"ACCUTANE. US Food and Drug Administration. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2008\/018662s059lbl.pdf. Accessed 19 June 2025."},{"key":"1681_CR57","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1001\/jamadermatol.2013.6746","volume":"149","author":"RC Blasiak","year":"2013","unstructured":"Blasiak RC, Stamey CR, Burkhart CN, et al. High-dose isotretinoin treatment and the rate of retrial, relapse, and adverse effects in patients with acne vulgaris. JAMA Dermatol. 2013;149:1392\u20138. https:\/\/doi.org\/10.1001\/jamadermatol.2013.6746.","journal-title":"JAMA Dermatol"},{"key":"1681_CR58","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1177\/1203475415595776","volume":"20","author":"J Tan","year":"2016","unstructured":"Tan J, Knezevic S, Boyal S, et al. Evaluation of evidence for acne remission with oral isotretinoin cumulative dosing of 120-150\u00a0mg\/kg. J Cutan Med Surg. 2016;20:13\u201320. https:\/\/doi.org\/10.1177\/1203475415595776.","journal-title":"J Cutan Med Surg"},{"key":"1681_CR59","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1016\/j.jaad.2020.10.030","volume":"84","author":"PT Tran","year":"2021","unstructured":"Tran PT, Berman HS, Leavitt E, et al. Analysis of factors associated with relapse in patients on their second course of isotretinoin for acne vulgaris. J Am Acad Dermatol. 2021;84:856\u20139. https:\/\/doi.org\/10.1016\/j.jaad.2020.10.030.","journal-title":"J Am Acad Dermatol"},{"key":"1681_CR60","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.jdin.2024.07.008","volume":"17","author":"H Maredia","year":"2024","unstructured":"Maredia H, Tollefson M, Keehr A, et al. The Mayo Clinic experience: once daily dosing of isotretinoin for acne. JAAD Int. 2024;17:82\u20133. https:\/\/doi.org\/10.1016\/j.jdin.2024.07.008.","journal-title":"JAAD Int"},{"key":"1681_CR61","first-page":"S3","volume":"7","author":"JJ Leyden","year":"2014","unstructured":"Leyden JJ, Del Rosso JQ, Baum EW. The use of isotretinoin in the treatment of acne vulgaris: clinical considerations and future directions. J Clin Aesthet Dermatol. 2014;7:S3\u201321.","journal-title":"J Clin Aesthet Dermatol"},{"key":"1681_CR62","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1111\/dth.12213","volume":"28","author":"HM Ahmad","year":"2015","unstructured":"Ahmad HM. Analysis of clinical efficacy, side effects, and laboratory changes among patients with acne vulgaris receiving single versus twice daily dose of oral isotretinoin. Dermatol Ther. 2015;28:151\u20137. https:\/\/doi.org\/10.1111\/dth.12213.","journal-title":"Dermatol Ther"},{"key":"1681_CR63","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1111\/ijd.15089","volume":"60","author":"H Fallah","year":"2021","unstructured":"Fallah H, Rademaker M. Isotretinoin in the management of acne vulgaris: practical prescribing. Int J Dermatol. 2021;60:451\u201360. https:\/\/doi.org\/10.1111\/ijd.15089.","journal-title":"Int J Dermatol"},{"key":"1681_CR64","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009435.pub2","volume":"11","author":"CS Costa","year":"2018","unstructured":"Costa CS, Bagatin E, Martimbianco ALC, et al. Oral isotretinoin for acne. Cochrane Database Syst Rev. 2018;11:CD009435. https:\/\/doi.org\/10.1002\/14651858.CD009435.pub2.","journal-title":"Cochrane Database Syst Rev"},{"key":"1681_CR65","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1159\/000090658","volume":"212","author":"G Qu\u00e9reux","year":"2006","unstructured":"Qu\u00e9reux G, Volteau C, N\u2019Guyen JM, et al. Prospective study of risk factors of relapse after treatment of acne with oral isotretinoin. Dermatology. 2006;212:168\u201376. https:\/\/doi.org\/10.1159\/000090658.","journal-title":"Dermatology"},{"key":"1681_CR66","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1159\/000090655","volume":"212","author":"F Ballanger","year":"2006","unstructured":"Ballanger F, Baudry P, N\u2019Guyen JM, et al. Heredity: a prognostic factor for acne. Dermatology. 2006;212:145\u20139. https:\/\/doi.org\/10.1159\/000090655.","journal-title":"Dermatology"},{"key":"1681_CR67","doi-asserted-by":"publisher","first-page":"S45","DOI":"10.1016\/s0190-9622(98)70444-x","volume":"39","author":"JJ Leyden","year":"1998","unstructured":"Leyden JJ. The role of isotretinoin in the treatment of acne: personal observations. J Am Acad Dermatol. 1998;39:S45\u20139. https:\/\/doi.org\/10.1016\/s0190-9622(98)70444-x.","journal-title":"J Am Acad Dermatol"},{"key":"1681_CR68","first-page":"692","volume":"124","author":"D Lehucher-Ceyrac","year":"1997","unstructured":"Lehucher-Ceyrac D, Chaspoux C, Weber MJ, et al. Acne, hyperandrogenism and oral isotretinoin resistance. 23 cases. Therapeutic implications. Ann Dermatol Venereol. 1997;124:692\u20135.","journal-title":"Ann Dermatol Venereol"},{"key":"1681_CR69","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2020.00450","volume":"8","author":"J Yang","year":"2020","unstructured":"Yang J, Yang H, Xu A, et al. A review of advancement on influencing factors of acne: an emphasis on environment characteristics. Front Public Health. 2020;8:450. https:\/\/doi.org\/10.3389\/fpubh.2020.00450.","journal-title":"Front Public Health"},{"key":"1681_CR70","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1001\/jamadermatol.2020.2330","volume":"156","author":"AM Secrest","year":"2020","unstructured":"Secrest AM, Hopkins ZH, Frost ZE, et al. Quality of life assessed using Skindex-16 scores among patients with acne receiving isotretinoin treatment. JAMA Dermatol. 2020;156:1098\u2013106. https:\/\/doi.org\/10.1001\/jamadermatol.2020.2330.","journal-title":"JAMA Dermatol"},{"key":"1681_CR71","doi-asserted-by":"publisher","first-page":"701","DOI":"10.2340\/00015555-1638","volume":"93","author":"SE Marron","year":"2013","unstructured":"Marron SE, Tomas-Aragones L, Boira S. Anxiety, depression, quality of life and patient satisfaction in acne patients treated with oral isotretinoin. Acta Derm Venereol. 2013;93:701\u20136. https:\/\/doi.org\/10.2340\/00015555-1638.","journal-title":"Acta Derm Venereol"},{"key":"1681_CR72","first-page":"104","volume":"29","author":"D \u0160imi\u0107","year":"2017","unstructured":"\u0160imi\u0107 D, Penavi\u0107 JZ, Babi\u0107 D, et al. Psychological status and quality of life in acne patients treated with oral isotretinoin. Psychiatr Danub. 2017;29:104\u201310.","journal-title":"Psychiatr Danub"},{"key":"1681_CR73","first-page":"80","volume":"20","author":"Y Yesilova","year":"2012","unstructured":"Yesilova Y, Bez Y, Ari M, et al. Effects of isotretinoin on social anxiety and quality of life in patients with acne vulgaris: a prospective trial. Acta Dermatovenerol Croat. 2012;20:80\u20133.","journal-title":"Acta Dermatovenerol Croat"},{"key":"1681_CR74","doi-asserted-by":"publisher","DOI":"10.33448\/rsd-v13i6.46119","volume":"13","author":"CB Scussel","year":"2024","unstructured":"Scussel CB, Franca JRde, Fedatto PF. Altera\u00e7\u00f5es laboratoriais bioqu\u00edmicas ap\u00f3s a administra\u00e7\u00e3o de isotretino\u00edna. Res Soc Dev. 2024;13:e12413646119. https:\/\/doi.org\/10.33448\/rsd-v13i6.46119.","journal-title":"Res Soc Dev"},{"key":"1681_CR75","doi-asserted-by":"publisher","DOI":"10.1111\/dth.13012","volume":"32","author":"H Aktas","year":"2019","unstructured":"Aktas H, Ertugrul G, Parlak M, et al. Long-term isotretinoin use does not cause parenchymal liver change: ultrasonographic study in 50 patients. Dermatol Ther. 2019;32:e13012. https:\/\/doi.org\/10.1111\/dth.13012.","journal-title":"Dermatol Ther"},{"key":"1681_CR76","unstructured":"EMA. Isotretinoin. https:\/\/www.ema.europa.eu\/en\/documents\/referral\/isotretinoin-article-29-referral-annex-i-ii-iii_en.pdf. Accessed 5 May 2025."},{"key":"1681_CR77","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.jaad.2019.06.025","volume":"82","author":"JS Barbieri","year":"2020","unstructured":"Barbieri JS, Shin DB, Wang S, et al. The clinical utility of laboratory monitoring during isotretinoin therapy for acne and changes to monitoring practices over time. J Am Acad Dermatol. 2020;82:72\u20139. https:\/\/doi.org\/10.1016\/j.jaad.2019.06.025.","journal-title":"J Am Acad Dermatol"},{"key":"1681_CR78","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.12998\/wjcc.v11.i11.2435","volume":"11","author":"YJ Park","year":"2023","unstructured":"Park YJ, Shin HY, Choi WK, et al. Optimal laboratory testing protocol for patients with acne taking oral isotretinoin. World J Clin Cases. 2023;11:2435\u201342. https:\/\/doi.org\/10.12998\/wjcc.v11.i11.2435.","journal-title":"World J Clin Cases"},{"key":"1681_CR79","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1111\/j.1365-4632.2008.03491.x","volume":"47","author":"Y Kaymak","year":"2008","unstructured":"Kaymak Y. Creatine phosphokinase values during isotretinoin treatment for acne. Int J Dermatol. 2008;47:398\u2013401. https:\/\/doi.org\/10.1111\/j.1365-4632.2008.03491.x.","journal-title":"Int J Dermatol"},{"key":"1681_CR80","doi-asserted-by":"publisher","first-page":"AB57","DOI":"10.1016\/j.jaad.2017.04.239","volume":"76","author":"F Cunningham","year":"2017","unstructured":"Cunningham F, Wylie G. Blood monitoring in isotretinoin therapy: creating additional expense? J Am Acad Dermatol. 2017;76:AB57\u201367.","journal-title":"J Am Acad Dermatol"},{"key":"1681_CR81","volume-title":"StatPearls","author":"HD Pile","year":"2025","unstructured":"Pile HD, Patel P, Sadiq NM. Isotretinoin. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2025."},{"key":"1681_CR82","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1007\/s40257-023-00765-9","volume":"24","author":"CL Yu","year":"2023","unstructured":"Yu CL, Chou PY, Liang CS, et al. Isotretinoin exposure and risk of inflammatory bowel disease: a systematic review with meta-analysis and trial sequential analysis. Am J Clin Dermatol. 2023;24:721\u201330. https:\/\/doi.org\/10.1007\/s40257-023-00765-9.","journal-title":"Am J Clin Dermatol"},{"key":"1681_CR83","unstructured":"Hoofnagle JH. LiverTox: clinical and research information on drug-induced liver injury. Bethesda (MD): National institute of diabetes and digestive and kidney diseases (2012). [Updated 20 June, 2025]. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK548318\/. Accessed 12 Nov 2025."},{"key":"1681_CR84","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1001\/jamadermatol.2014.2402","volume":"151","author":"S Krishna","year":"2015","unstructured":"Krishna S, Okhovat JP, Kim J, et al. Influence of \u03c9-3 fatty acids on triglyceride levels in patients using isotretinoin. JAMA Dermatol. 2015;151:101\u20132. https:\/\/doi.org\/10.1001\/jamadermatol.2014.2402.","journal-title":"JAMA Dermatol"},{"key":"1681_CR85","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1001\/jamadermatol.2023.4579","volume":"160","author":"NKW Tan","year":"2024","unstructured":"Tan NKW, Tang A, MacAlevey NCYL, et al. Risk of suicide and psychiatric disorders among isotretinoin users: a meta-analysis. JAMA Dermatol. 2024;160:54\u201362. https:\/\/doi.org\/10.1001\/jamadermatol.2023.4579.","journal-title":"JAMA Dermatol"},{"key":"1681_CR86","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.29825","volume":"14","author":"MA Miqdad","year":"2022","unstructured":"Miqdad MA, Alatta L, Abdelsamad A, et al. Isotretinoin-induced inflammatory bowel disease: is there a real association? Cureus. 2022;14:e29825. https:\/\/doi.org\/10.7759\/cureus.29825.","journal-title":"Cureus"},{"key":"1681_CR87","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.sder.2008.07.002","volume":"27","author":"M Brelsford","year":"2008","unstructured":"Brelsford M, Beute TC. Preventing and managing the side effects of isotretinoin. Semin Cutan Med Surg. 2008;27:197\u2013206. https:\/\/doi.org\/10.1016\/j.sder.2008.07.002.","journal-title":"Semin Cutan Med Surg"},{"key":"1681_CR88","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph19116463","volume":"19","author":"J Kapa\u0142a","year":"2022","unstructured":"Kapa\u0142a J, Lewandowska J, Placek W, et al. Adverse events in isotretinoin therapy: a single-arm meta-analysis. Int J Environ Res Public Health. 2022;19:6463. https:\/\/doi.org\/10.3390\/ijerph19116463.","journal-title":"Int J Environ Res Public Health"},{"key":"1681_CR89","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1111\/j.1473-2165.2009.00455.x","volume":"8","author":"MI Herane","year":"2009","unstructured":"Herane MI, Fuenzalida H, Zegpi E, et al. Specific gel-cream as adjuvant to oral isotretinoin improved hydration and prevented TEWL increase\u2014a double-blind, randomized, placebo-controlled study. J Cosmet Dermatol. 2009;8:181\u20135. https:\/\/doi.org\/10.1111\/j.1473-2165.2009.00455.x.","journal-title":"J Cosmet Dermatol"},{"key":"1681_CR90","doi-asserted-by":"publisher","first-page":"67","DOI":"10.18203\/issn.2455-4529.IntJResDermatol20230453","volume":"9","author":"ST Tahiliani","year":"2023","unstructured":"Tahiliani ST, Saraf VV, Jadhav SP, et al. Evaluation of effectiveness and tolerability of a moisturiser as an adjuvant to isotretinoin therapy for acne: a real-world evidence. Int J Res Dermatol. 2023;9:67\u201372. https:\/\/doi.org\/10.18203\/issn.2455-4529.IntJResDermatol20230453.","journal-title":"Int J Res Dermatol"},{"issue":"4","key":"1681_CR91","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1111\/pde.15595","volume":"41","author":"K Miller","year":"2024","unstructured":"Miller K, McKean A, Hand J, et al. The occurrence of mental health symptoms in isotretinoin-treated adolescents. Pediatr Dermatol. 2024;41(4):635\u201340. https:\/\/doi.org\/10.1111\/pde.15595.","journal-title":"Pediatr Dermatol"},{"key":"1681_CR92","unstructured":"iPLEDGE REMS. US Food and Drug Administration. https:\/\/www.fda.gov\/media\/166485\/download. Accessed 5 May 2025."},{"key":"1681_CR93","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/0190-9622(92)70088-w","volume":"26","author":"WS Dai","year":"1992","unstructured":"Dai WS, LaBraico JM, Stern RS. Epidemiology of isotretinoin exposure during pregnancy. J Am Acad Dermatol. 1992;26:599\u2013606. https:\/\/doi.org\/10.1016\/0190-9622(92)70088-w.","journal-title":"J Am Acad Dermatol"},{"key":"1681_CR94","doi-asserted-by":"publisher","first-page":"239","DOI":"10.4103\/idoj.IDOJ_101_19","volume":"11","author":"H Jajoria","year":"2020","unstructured":"Jajoria H, Mysore V. Washout period for pregnancy post isotretinoin therapy. Indian Dermatol Online J. 2020;11:239\u201342. https:\/\/doi.org\/10.4103\/idoj.IDOJ_101_19.","journal-title":"Indian Dermatol Online J"},{"key":"1681_CR95","unstructured":"Central Drugs Standard Control Organisation (CDSCO) New Delhi (IN): CDSCO; 2018. https:\/\/cdsco.gov.in\/opencms\/resources\/UploadCDSCOWeb\/2018\/UploadPublic_NoticesFiles\/Isotretinoinlates.pdf. Accessed 21 May 2025."},{"key":"1681_CR96","doi-asserted-by":"publisher","first-page":"539","DOI":"10.4103\/ijdvl.IJDVL_77_17","volume":"84","author":"P Kumar","year":"2018","unstructured":"Kumar P, Das A, Lal NR, et al. Safety of important dermatological drugs (retinoids, immune suppressants, anti androgens and thalidomide) in reproductively active males with respect to pregnancy outcome: a brief review of literature. Indian J Dermatol Venereol Leprol. 2018;84:539\u201346. https:\/\/doi.org\/10.4103\/ijdvl.IJDVL_77_17.","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"1681_CR97","doi-asserted-by":"publisher","first-page":"29","DOI":"10.2165\/00128071-200506010-00004","volume":"6","author":"DI Friedman","year":"2005","unstructured":"Friedman DI. Medication-induced intracranial hypertension in dermatology. Am J Clin Dermatol. 2005;6:29\u201337. https:\/\/doi.org\/10.2165\/00128071-200506010-00004.","journal-title":"Am J Clin Dermatol"},{"key":"1681_CR98","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1067\/mjd.2001.115966","volume":"45","author":"JS Strauss","year":"2001","unstructured":"Strauss JS, Leyden JJ, Lucky AW, et al. Safety of a new micronized formulation of isotretinoin in patients with severe recalcitrant nodular acne: a randomized trial comparing micronized isotretinoin with standard isotretinoin. J Am Acad Dermatol. 2001;45:196\u2013207. https:\/\/doi.org\/10.1067\/mjd.2001.115966.","journal-title":"J Am Acad Dermatol"},{"key":"1681_CR99","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1067\/mjd.2001.115965","volume":"45","author":"JS Strauss","year":"2001","unstructured":"Strauss JS, Leyden JJ, Lucky AW, et al. A randomized trial of the efficacy of a new micronized formulation versus a standard formulation of isotretinoin in patients with severe recalcitrant nodular acne. J Am Acad Dermatol. 2001;45:187\u201395. https:\/\/doi.org\/10.1067\/mjd.2001.115965.","journal-title":"J Am Acad Dermatol"},{"key":"1681_CR100","doi-asserted-by":"publisher","DOI":"10.18203\/2320-6012.ijrms20220998","volume":"10","author":"S Kandhari","year":"2022","unstructured":"Kandhari S, Girdhar M, Kulkarni DS, et al. Expert consensus on the management of acne in India. Int J Res Med Sci. 2022;10:980. https:\/\/doi.org\/10.18203\/2320-6012.ijrms20220998.","journal-title":"Int J Res Med Sci"},{"key":"1681_CR101","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1001\/jamadermatol.2017.2077","volume":"153","author":"LK Spring","year":"2017","unstructured":"Spring LK, Krakowski AC, Alam M, et al. Isotretinoin and timing of procedural interventions: a systematic review with consensus recommendations. JAMA Dermatol. 2017;153:802\u20139. https:\/\/doi.org\/10.1001\/jamadermatol.2017.2077.","journal-title":"JAMA Dermatol"},{"key":"1681_CR102","doi-asserted-by":"publisher","first-page":"186","DOI":"10.4103\/JCAS.JCAS_110_17","volume":"10","author":"V Mysore","year":"2017","unstructured":"Mysore V, Mahadevappa OH, Barua S, et al. Standard guidelines of care: performing procedures in patients on or recently administered with isotretinoin. J Cutan Aesthet Surg. 2017;10:186\u201394. https:\/\/doi.org\/10.4103\/JCAS.JCAS_110_17.","journal-title":"J Cutan Aesthet Surg"},{"key":"1681_CR103","first-page":"20","volume":"4","author":"EM Wise","year":"2011","unstructured":"Wise EM, Graber EM. Clinical pearl: comedone extraction for persistent macrocomedones while on isotretinoin therapy. J Clin Aesthet Dermatol. 2011;4:20\u20131.","journal-title":"J Clin Aesthet Dermatol"},{"key":"1681_CR104","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1016\/j.jaad.2004.02.012","volume":"50","author":"LA Goldsmith","year":"2004","unstructured":"Goldsmith LA, Bolognia JL, Callen JP, et al. American Academy of Dermatology consensus conference on the safe and optimal use of isotretinoin: summary and recommendations. J Am Acad Dermatol. 2004;50:900\u20136. https:\/\/doi.org\/10.1016\/j.jaad.2004.02.012.","journal-title":"J Am Acad Dermatol"},{"key":"1681_CR105","doi-asserted-by":"publisher","DOI":"10.5070\/d3218028439","volume":"21","author":"R Wilken","year":"2015","unstructured":"Wilken R, Sharma A, Patel F, et al. Successful treatment of palmoplantar pustulosis with isotretinoin. Dermatol Online J. 2015;21:13030\/qt4b4776gb. https:\/\/doi.org\/10.5070\/d3218028439.","journal-title":"Dermatol Online J"},{"key":"1681_CR106","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1111\/j.1525-1470.2007.00524.x","volume":"24","author":"H Al-Shobaili","year":"2007","unstructured":"Al-Shobaili H, Al-Khenaizan S. Childhood generalized pustular psoriasis: successful treatment with isotretinoin. Pediatr Dermatol. 2007;24:563\u20134. https:\/\/doi.org\/10.1111\/j.1525-1470.2007.00524.x.","journal-title":"Pediatr Dermatol"},{"key":"1681_CR107","doi-asserted-by":"publisher","first-page":"125","DOI":"10.4103\/2319-7250.172464","volume":"17","author":"K Pratyusha","year":"2016","unstructured":"Pratyusha K, Sree P, Reddy BS. Successful outcome of lamellar ichthyosis with oral retinoid therapy: a series of six cases. Indian J Paediatr Dermatol. 2016;17:125\u20138. https:\/\/doi.org\/10.4103\/2319-7250.172464.","journal-title":"Indian J Paediatr Dermatol"},{"key":"1681_CR108","doi-asserted-by":"publisher","first-page":"164","DOI":"10.5114\/ada.2024.146870","volume":"42","author":"A De","year":"2025","unstructured":"De A, Halder S, Dhoot D, Balasubramanian A, Barkate H. A prospective, randomised comparative study to evaluate safety, tolerability, and efficacy of topical minocycline gel 4% plus oral isotretinoin against oral isotretinoin only in Indian patients with moderate-to-severe acne vulgaris. Adv Dermatol Allergol. 2025;42:164\u201370. https:\/\/doi.org\/10.5114\/ada.2024.146870.","journal-title":"Adv Dermatol Allergol"},{"key":"1681_CR109","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1111\/j.1468-3083.2008.03022.x","volume":"23","author":"K Sardana","year":"2009","unstructured":"Sardana K, Garg VK, Sehgal VN, Mahajan S, Bhushan P. Efficacy of fixed low-dose isotretinoin (20\u00a0mg, alternate days) with topical clindamycin gel in moderately severe acne vulgaris. J Eur Acad Dermatol Venereol. 2009;23:556\u201360. https:\/\/doi.org\/10.1111\/j.1468-3083.2008.03022.x.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1681_CR110","doi-asserted-by":"publisher","first-page":"417","DOI":"10.5021\/ad.2018.30.4.417","volume":"30","author":"JE Kim","year":"2018","unstructured":"Kim JE, Park AY, Lee SY, Park YL, Whang KU, Kim HJ. Comparison of the efficacy of azithromycin versus doxycycline in acne vulgaris: a meta-analysis of randomized controlled trials. Ann Dermatol. 2018;30:417\u201326. https:\/\/doi.org\/10.5021\/ad.2018.30.4.417.","journal-title":"Ann Dermatol"},{"key":"1681_CR111","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.clindermatol.2009.03.006","volume":"28","author":"AD Katsambas","year":"2010","unstructured":"Katsambas AD, Dessinioti C. Hormonal therapy for acne: why not as first line therapy? Facts and controversies. Clin Dermatol. 2010;28:17\u201323. https:\/\/doi.org\/10.1016\/j.clindermatol.2009.03.006.","journal-title":"Clin Dermatol"},{"key":"1681_CR112","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.ijwd.2019.10.007","volume":"6","author":"A Feily","year":"2019","unstructured":"Feily A, Taheri T, Meier-Schiesser B, et al. The effect of low-dose isotretinoin therapy on serum androgen levels in women with acne vulgaris. Int J Womens Dermatol. 2019;6:102\u20134. https:\/\/doi.org\/10.1016\/j.ijwd.2019.10.007.","journal-title":"Int J Womens Dermatol"}],"container-title":["Dermatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-026-01681-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13555-026-01681-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-026-01681-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T14:54:05Z","timestamp":1780584845000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13555-026-01681-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,31]]},"references-count":112,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["1681"],"URL":"https:\/\/doi.org\/10.1007\/s13555-026-01681-6","relation":{},"ISSN":["2193-8210","2190-9172"],"issn-type":[{"value":"2193-8210","type":"print"},{"value":"2190-9172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,31]]},"assertion":[{"value":"11 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Sanjiv Kandhari, Jayakar Thomas, Niti Khunger, Maya Vedamurthy, Kiran Godse, Abir Saraswat, Nina Madnani, Vijay Somani, Sushil Tahiliani, Bela Shah, C. R. Srinivas, Asit Mittal, Mukesh Girdhar, Maleeka Sachdeva, Sachin Varma, Manjunath Shenoy, Shyamanta Barua, Abhishek De, Akshay Jain, and Aseem Sharma have nothing to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This Delphi-based consensus did not involve patient data, human biological samples, or clinical interventions. It was limited to obtaining expert opinions from healthcare professionals, and as such, it was considered exempt from formal ethics committee review. All panelists were informed about the consensus objectives, methodology, and intended use of the findings. Informed consent was obtained from all panel members. Participation was entirely voluntary, and responses were anonymized to maintain confidentiality.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}